フォックス・ヴィオラ博士は、BKZゾーリンゲン血液腫瘍科・緩和医療科の主任医師です。同クリニックは、認定された集学的腫瘍センターです。フォックス博士は、ドイツおよびヨーロッパにおける腫瘍性疾患の薬物療法の第一人者であり、15年以上の臨床経験を有しています。
同博士は、ドイツ腫瘍学・血液腫瘍学会（GDHO）、ドイツ医師会、およびアメリカがん研究学会に所属しています。また、分子生物学の研究にも従事しており、その研究成果はがん治療および分子診断の発展に貢献しています。
主な専門領域は、化学療法、免疫療法、分子標的療法、および放射線療法です。フォックス博士は、革新的な治療法と患者への細やかな配慮で知られています。その取り組みにより、高い治癒率を達成し、同僚からの高い評価を得ています。
セヴリーヌ・イボラ博士は、ゾーリンゲン市立病院の産婦人科部門を統括し、低侵襲診断および治療を専門としています。
Dr. Derya Can has been an Assistant Professor of Dermatology at Medipol Health Group since 2021. She diagnoses and treats diseases of the skin, hair, nails, and mucosa. Her areas of expertise include eczema, atopic dermatitis, acne, psoriasis, sexually transmitted infections, warts, herpes, shingles, and fungal infections.
Dr. Can manages both benign and malignant skin tumors. She also treats hair and nail disorders, vitiligo, and other common skin conditions. She performs advanced procedures such as hair transplantation and PRP therapy for hair loss.
Dr. Marc Ulrich Becher is an interventional cardiologist and heart failure specialist at Städtisches Klinikum Solingen. He is known for performing advanced procedures such as coronary angiography, radiofrequency ablation with 3D mapping, carotid angioplasty, and stenting.
Dr. Becher’s clinic carries out about 3,000 to 4,000 diagnostic and therapeutic procedures each year. These include complex coronary interventions, catheter-based valve replacements, and structural heart procedures. He is experienced in using advanced imaging techniques like IVUS and OCT for accurate diagnosis and treatment planning.
Dr. Becher is dedicated to providing thorough and compassionate care. He uses modern therapies for both acute and chronic cardiovascular diseases, focusing on patient safety and positive outcomes.
Dr. Nurullah Bulut is an ophthalmology specialist at Memorial Göztepe (2025–) and Memorial Bahçelievler (2023–). He previously worked at the University of Health Sciences Kartal Dr. Lütfi Kırdar as a specialist (2013–2022) and as an associate professor (2022–2023). He received the title of associate professor (Doçent) in 2022.
He has 26 peer-reviewed articles, 29 conference papers, one book chapter, and a patent application for an intraocular lens design. He is a member of EURETINA YOURS, the Turkish Medical Association, and the Turkish Ophthalmological Society.
Training: ESCRS PRK/LASEK/Epi-LASIK/LASIK course (2011); ocular electrophysiology, Germany (2011); vitreoretinal surgery observer program, University of Chicago (2014). Education: MD, Atatürk University (2008). Ophthalmology specialization, Kartal Dr. Lütfi Kırdar (2009–2013).
Dr. Rahsan Adviye is a Neurology Specialist at Memorial Göztepe Hospital (2025–present). She has over 20 years of specialist practice in Istanbul. She previously worked at Fatih Medical Park (2004–2008) and Hisar Hospital (2009–2010). From 2010 to 2025, she served as a Neurology Specialist and instructor at the University of Health Sciences, Kartal Dr. Lütfi Kirdar City Hospital. This post included 15 years of academic teaching.
She completed her Neurology residency at Istanbul University Cerrahpaşa Faculty of Medicine (1999–2004). She earned her M.D. there in the English-language program (1991–1998). She is a member of the Turkish Neurology Society, the Istanbul Medical Chamber, and the EEG-EMG Clinical Neurophysiology Society. She attended the Master’s Program in Clinical Neurophysiology at Istanbul University. She has also taken part in many national and international scientific meetings.
Education:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Membership in societies:
Expert of scientific journals
Close co-operation with leading surgeons
Membership of the German Medical Association
Specialities:
Introduction of new and modern techniques in the field of oncological surgery
General and visceral surgery
Minimally invasive surgery
Gastrointestinal oncology surgery
Oncological surgery
Haemorrhoids treatment
Additional clinical specialisation in minimally invasive and hernia surgery
Surgery and transplantation of the pancreas
Work Experience:
2005: Specialist in the field of surgery
2008: Appointed Senior Consultant specialising in pancreatic surgery and transplantation
2010: Coordinator of the Pancreatic Cancer Centre (Oncocert)
2013: Specialist in visceral surgery
2014: Managing Senior Physician, additional clinical specialisation in minimally invasive and hernia surgery
2019: Chief Surgeon of the Colorectal Cancer Centre Bochum (the first certified colorectal cancer centre in Germany and one of the first certified leading colorectal centres in Europe)
2021: Chief Surgeon of the Department of Surgery at the Academic Hospital Solingen
Thanks to the professor and his team, the department has been modernised by introducing modern surgical methods of treatment and especially improved methods of post-operative recovery. The Department of Surgery at the Solingen Clinic is now further expanding its focus on minimally invasive surgery in the direction of robotics. The clinic has allocated a huge budget for the purchase of state-of-the-art equipment in order to offer patients a full range of surgical methods for the treatment of benign and malignant diseases of the oesophagus, lungs, stomach, liver, pancreas and intestines according to current guidelines and using the most modern technical equipment.
Professor Schenker is an active researcher and lecturer. He lectures at medical universities and organises seminars and workshops for colleagues. He cooperates closely with the Cancer Centre, the Pancreatic Cancer Treatment Centre, the Intestinal Cancer Treatment Centre and the Interregional Trauma Centre.
Dr. Mustafa Serkan Durdu is a cardiovascular surgeon at Memorial Göztepe Hospital. He previously worked at Memorial Ankara Hospital and Ankara University. He focuses on minimally invasive heart and valve surgery. His work includes right anterior minithoracotomy and combined procedures.
He has published peer-reviewed studies on sutureless aortic valve replacement. His work also covers multiple valve implantation via right anterior thoracotomy, valve surgery with right coronary artery bypass, and molecular markers of chronic atrial fibrillation. His papers have appeared in The Journal of Thoracic and Cardiovascular Surgery, Heart, Lung and Circulation, and The Thoracic and Cardiovascular Surgeon.
He earned his MD from Erciyes University. He completed cardiovascular surgery training at Ankara University and additional training in biotechnology and genetics. He is a member of EACTS, ISMICS, MIRC, and Turkish societies for cardiovascular surgery, vascular surgery, and hematology.
Dr. João Lima Gabriel is a Family Medicine physician with over 15 years of experience in public and private care. Since 2019, he has been Medical Director at Corporación Dermoestética. He leads clinical teams and oversees weight loss programs, aesthetic medicine, dermatologic care, and facial and body treatments.
He has practiced at Hospital da Luz, CUF, and USF Oriente. He has also mentored National Health System trainees as a clinical tutor. He completed specialization in aesthetic medicine at the University of Córdoba. He is multilingual.
Clinical focus: obesity management, hyperhidrosis, facial rejuvenation, injectables, laser therapies, chemical peels, IPL, mesotherapy, and hair restoration. He provides care with a holistic, individualized approach and clear communication.
Dr. Bulen Can is an endocrinology specialist at Memorial Göztepe Hospital (2025–present). He previously worked at Acıbadem Ataşehir (2024–2025). From 2017 to 2024, he was a faculty member in the Division of Endocrinology at Istanbul Medeniyet University. He also practiced at Ankara Numune, Kastamonu Dr. M. İslamoğlu, and Ümraniye Training and Research Hospitals. He has been an endocrinology specialist since 2013.
He completed subspecialty training in Endocrinology and Metabolic Diseases at Istanbul University, Istanbul Faculty of Medicine (2009–2013). Before that, he finished his Internal Medicine residency at Bezm‑i Âlem Vakıf Gureba (2003–2009). He received his M.D. from the Istanbul Faculty of Medicine. He is a member of TEMD, TİHUD, TTB, and the Istanbul Medical Chamber. He attended the 46th TEMD Congress (2025), Aydın Endocrine Days (2022), and Clinical Research Training (2017).
Dr. Sumeyre Seda Ertekin is a general surgeon and surgical oncologist at Memorial Göztepe Hospital (2025–present). She previously worked at Academic Hospital (1999–2025), Marmara University Hospital (1991–2010), Gülhane Military Medical Academy Haydarpaşa (1997–1998), and Haukeland University Hospital in Bergen, Norway (2000–2008).
She holds UEMS European Board of Surgery certification in General Surgery (2012) and a subspecialty in Breast Surgery (2012). She completed Ministry of Health subspecialty training in Surgical Oncology (2012). She finished her General Surgery residency at Marmara University (1991–1996).
Memberships and roles: Founding Member, Breast Surgery Association. Country Coordinator, OPBS. Member, EORTC‑BCG, BRESO, IBUS, SENATURK, and the Istanbul Breast Diseases Society. Member, Global Technical Oversight Group (THET–ABS). Honorary Member of the Bulgarian Surgical Society, the Romanian Society of Breast Surgery and Oncology, and ABSI (India).
Dr. Vafa Guliyeva is a pediatric rheumatologist at Memorial Göztepe Hospital in Istanbul. She previously worked at Memorial Şişli and LIV Bona Dea. Before that, she was a pediatrics specialist at Florence Nightingale Hospital.
Training: Pediatric rheumatology subspecialty at Istanbul University and Istanbul Cerrahpaşa University. Pediatrics residency at Istanbul Medeniyet University.
Achievements: Author of 20 international and 3 national peer-reviewed articles. Presented 3 international and 20 national conference papers. Contributed to 4 book chapters. Principal investigator of a BAP scientific project.
Memberships: Turkish Medical Association (TTB). Pediatric Rheumatology Association. Paediatric Rheumatology European Society (PReS).
Under his leadership, the hospital is actively expanding its services, including paediatric cardiology and intensive care, and is planning to establish an interdisciplinary center for parents and children on the basis of the Department of Paediatrics.
Dr. Propson's many years of experience have established him as a leading expert in neonatology and paediatric cardiology in Germany and Europe. His dedication and commitment to the highest level of care for young patients is reflected in his work. Dr. Propson's research and scientific publications demonstrate his in-depth knowledge and commitment to development in paediatrics.
For many years Dr. Propson worked as a leading physician in the Department of Paediatrics and Adolescent Medicine at the Leverkusen Clinic in Leverkusen, Germany, where he was also responsible for managing the paediatric intensive care unit. In addition to his primary work, Dr. Propson devotes a great deal of time to continuing education to ensure that his patients receive the most up-to-date treatments in his department.
His unique professional qualities and qualifications set him apart from other physicians. Dr. Propson's patients can rest assured that they are in good hands at the Department of Paediatrics and Adolescent Medicine at the Academic Hospital Solingen.
Membership in societies:
German Association of Physicians
Expert of scientific journals
Specialisations:
Emergency medicine
Intensive care
Paediatric cardiology
Neonatology
Work Experience:
2006: Graduation from the Faculty of Medicine
2006 - 2011: Specialization as a specialist in paediatrics and adolescent medicine.
2011 - 2023: Lead physician in the Department of Paediatrics and Adolescent Medicine at the Leverkusen Clinic.
2023: Chief physician in the Department of Paediatrics at the Academic Hospital Solingen.
Dr. Ozgur Kilickesmez is an interventional neuroradiology and interventional radiology specialist at Memorial Goztepe Hospital in Istanbul (2025–present). He previously worked at Medicana Atakoy and Zincirlikuyu (2024–2025). He also served at Basaksehir Cam ve Sakura City Hospital (2020–2024), Istanbul Training and Research Hospital (2012–2020), and Guy’s and St Thomas’ Hospital in London (2011–2012).
He is a Professor at the University of Health Sciences (2020). He was an Associate Professor at Yeditepe University Hospital (2010). He completed training in interventional oncology at King’s College University (2011) and in interventional radiology at Cerrahpasa (2010). He provides international training in minimally invasive tumor therapy, non-surgical thyroid interventions, new-generation embolization, and stent-based brain aneurysm treatment. He is a member of RSNA, ESR, CIRSE, and ESNR. He also belongs to Turkish radiology, neuroradiology, interventional radiology, and oncology societies.
Dr. Mustafa Serkan Durdu is a cardiovascular surgeon at Memorial Ankara Hospital (2022–present). He previously worked at the Ankara University Department of Cardiovascular Surgery. His focus is minimally invasive valve surgery. He performs right anterior minithoracotomy, sutureless aortic valve replacement, multiple valve implantation, and combined valve surgery with right coronary artery bypass.
He has peer-reviewed publications in J Thorac Cardiovasc Surg, Thorac Cardiovasc Surg, Heart Lung Circ, Semin Thorac Cardiovasc Surg, and Cardiovasc Ther. His work includes studies on molecular signatures of chronic atrial fibrillation in primary mitral regurgitation. Qualifications: Cardiovascular Surgery specialization (Ankara University) and MD (Erciyes University). Memberships: EACTS, ISMICS, MIRC, Turkish Society of Cardiovascular Surgery, National Society of Vascular Surgery, and Turkish Society of Hematology.
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences